CX3CL1 and interstitial lung disease: A treatment with anti-CX3CL1 mAb suppressed the infiltration of M1 macrophages, but not M2 macrophages, into the alveolar space, but did not attenuate lung fibrosis, suggesting the potential of CX3CL1 to regulate macrophage infiltration in SKG-ILD.